ramosetron has been researched along with granisetron in 37 studies
| Studies (ramosetron) | Trials (ramosetron) | Recent Studies (post-2010) (ramosetron) | Studies (granisetron) | Trials (granisetron) | Recent Studies (post-2010) (granisetron) |
|---|---|---|---|---|---|
| 194 | 94 | 83 | 59 | 0 | 16 |
| 194 | 94 | 83 | 1,149 | 466 | 243 |
| Protein | Taxonomy | ramosetron (IC50) | granisetron (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 4.3 | |
| D | Rattus norvegicus (Norway rat) | 3.8019 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 3.8019 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 3.8019 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 3.8019 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 3.8019 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 1.76 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.7702 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 5 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 1.76 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (32.43) | 18.2507 |
| 2000's | 16 (43.24) | 29.6817 |
| 2010's | 7 (18.92) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, NM; Brady, CA; Butler, AS; Choo, SH; Cioffi, CL; Cohen, ML; Dobritsa, S; Earley, WG; Fitzpatrick, K; Guo, C; Guzzo, PR; Hassler, C; Manning, DD; Masih, L; Naginskaya, J; Ryan, KN; Sikkander, MI; Usyatinsky, A; Wierschke, JD; Zhang, Z | 1 |
| Ito, H; Iwai, A; Kamato, T; Katsuyama, Y; Miyata, K; Nishida, A; Ohta, M; Tsutsumi, R; Yamano, M; Yuki, H | 1 |
| Akuzawa, S; Ito, H; Kamato, T; Kiso, T; Miyata, K; Nishida, A; Tsutsumi, R; Yamano, M | 1 |
| Honda, K; Ito, H; Kamato, T; Miyata, K; Nishida, A; Tsutsumi, R; Yamano, M; Yuki, H | 1 |
| Ichikawa, S; Ishii, A; Karasawa, A; Kishibayashi, N; Yokoyama, T | 1 |
| Akuzawa, S; Kamato, T; Miyata, K; Yamano, M | 1 |
| Tsukagoshi, S | 1 |
| Kamato, T; Miyata, K; Nagakura, Y; Yamano, M | 1 |
| Akuzawa, S; Ito, H; Yamaguchi, T | 1 |
| Fujii, Y; Saitoh, Y; Tanaka, H; Toyooka, H | 2 |
| Fujii, Y; Kobayashi, N; Tanaka, H | 1 |
| Blower, PR; Endo, T; Hamaue, N; Hirafuji, M; Kitamura, N; Minami, M; Nemoto, M; Ogawa, T; Teramoto, Y; Yasuda, E | 1 |
| Akutagawa, N; Ishioka, S; Ito, E; Kiya, T; Kudo, R; Sagae, S; Saito, T; Sugimura, M; Umemura, K | 1 |
| Fujii, Y; Kobayashi, N; Saitoh, Y | 1 |
| Fujii, Y; Ito, M; Tanaka, H | 1 |
| Nakayama, S; Noda, T; Torii, Y | 1 |
| Feng, F; He, Y; Zhang, P | 1 |
| Akamatsu, H; Mikawa, K; Nishina, K; Niwa, Y; Shiga, M | 1 |
| Fujii, Y; Tanaka, H | 1 |
| Cho, OG; Kim, JH; Kim, JS; Lee, JY; Lee, SY; Park, SY; Soh, EY | 1 |
| Chen, G; Feng, F; He, Y; Li, L; Li, Y; Zhang, P; Zhou, M | 1 |
| Higuchi, K; Koizumi, W; Nagaba, S; Nakayama, N; Nonaka, M; Saigenji, K; Tanabe, S; Yago, K | 1 |
| Liu, YP; Shi, J; Teng, YE; Zhang, JD | 1 |
| Hamada, J; Kai, Y; Kochi, M; Kuratsu, J; Makino, K; Morioka, M; Nakamura, H; Yano, S | 1 |
| Changkuingdee, N; Cheirsilpa, A; Chulaka, K; Sinthusake, T; Songsakkaesorn, A; Visawaprasit, S | 1 |
| Hashimoto, R; Ikeda, K; Kurokawa, N; Okamoto, Y; Takagi, T; Takenaka, M; Ueda, T; Uejima, E | 1 |
| Iwase, O; Okuyama, K; Ozeki, T; Yamada, Y; Yoshimoto, K | 1 |
| Ayuhara, H; Okuyama, K; Ozeki, T; Takayanagi, R; Yamada, Y; Yokoyama, H; Yoshimoto, K | 1 |
| Carlisle, JB | 1 |
| Cyranoski, D | 1 |
| Akashi, K; Arita, S; Ariyama, H; Baba, E; Komoda, M; Kumagai, H; Kusaba, H; Nagata, K; Nakano, M; Okumura, Y; Takaishi, S; Tamura, S; Uchida, M | 1 |
| Chang, YG; Lee, KB; Lee, WS; Lim, S | 1 |
| Arora, MK; Borle, A; Gouda, D; Goudra, B; Makkar, JK; Singh, PM; Sinha, A; Trikha, A | 1 |
| Abushouk, AI; Ahmed, H; Al Nahrawi, S; Attia, A; Awad, K; Elsherbeny, MY; Mustafa, SM | 1 |
| Chuma, M; Goda, M; Hamada, Y; Hamano, H; Hayama, T; Horinouchi, Y; Ikeda, Y; Imai, T; Ishida, S; Ishizawa, K; Kirino, Y; Mitsuhashi, C; Nakamura, T; Niimura, T; Okada, N; Sakamoto, K; Shinomiya, K; Suzuki, Y; Takechi, K; Tsujinaka, K; Yagi, K; Yanagawa, H; Zamami, Y | 1 |
| Aizawa, F; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Izawa-Ishizawa, Y; Kanda, M; Murai, Y; Niimura, T; Okada, N; Yagi, K; Yoshida, A; Yoshioka, T; Zamami, Y | 1 |
4 review(s) available for ramosetron and granisetron
| Article | Year |
|---|---|
[A new antiemetic ramosetron hydrochloride].
Topics: Animals; Antiemetics; Antineoplastic Agents; Benzimidazoles; Granisetron; Guinea Pigs; Humans; Male; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1997 |
A meta-analysis of prevention of postoperative nausea and vomiting: randomised controlled trials by Fujii et al. compared with other authors.
Topics: Antiemetics; Benzimidazoles; Data Interpretation, Statistical; Droperidol; Drug Interactions; Drug Therapy, Combination; Granisetron; Humans; Meta-Analysis as Topic; Postoperative Nausea and Vomiting; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome | 2012 |
Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
Topics: Adult; Anesthesia, General; Antiemetics; Benzimidazoles; Granisetron; Humans; Isoquinolines; Ondansetron; Palonosetron; Postoperative Nausea and Vomiting; Quinuclidines; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome | 2016 |
Dexamethasone combined with other antiemetics versus single antiemetics for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: An updated systematic review and meta-analysis.
Topics: Antiemetics; Benzimidazoles; Cholecystectomy, Laparoscopic; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Isoquinolines; Metoclopramide; Ondansetron; Palonosetron; Postoperative Nausea and Vomiting; Quinuclidines; Randomized Controlled Trials as Topic | 2016 |
16 trial(s) available for ramosetron and granisetron
| Article | Year |
|---|---|
Comparison of ramosetron and granisetron for preventing postoperative nausea and vomiting after gynecologic surgery.
Topics: Adult; Aged; Antiemetics; Benzimidazoles; Double-Blind Method; Female; Granisetron; Gynecologic Surgical Procedures; Humans; Middle Aged; Postoperative Nausea and Vomiting; Prospective Studies; Serotonin Antagonists | 1999 |
Ramosetron vs granisetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy.
Topics: Adult; Aged; Antiemetics; Benzimidazoles; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Granisetron; Humans; Middle Aged; Postoperative Nausea and Vomiting; Prospective Studies; Serotonin Antagonists | 1999 |
Prevention of nausea and vomiting after middle ear surgery: granisetron versus ramosetron.
Topics: Adult; Aged; Antiemetics; Benzimidazoles; Double-Blind Method; Ear, Middle; Female; Granisetron; Humans; Male; Mastoid; Middle Aged; Postoperative Nausea and Vomiting; Prospective Studies; Serotonin Antagonists; Treatment Outcome; Tympanoplasty | 1999 |
[Effects of oral 5-HT3 antagonists on chemotherapy-induced emesis in patients with gynecologic cancers].
Topics: Administration, Oral; Antiemetics; Benzimidazoles; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Indoles; Middle Aged; Nausea; Ondansetron; Paclitaxel; Serotonin Antagonists; Tropisetron; Vomiting | 2000 |
Prevention of vomiting after tonsillectomy in children: granisetron versus ramosetron.
Topics: Antiemetics; Benzimidazoles; Child; Child, Preschool; Female; Granisetron; Humans; Infusions, Intravenous; Male; Postoperative Complications; Serotonin Antagonists; Tonsillectomy; Treatment Outcome; Vomiting | 2001 |
Ramosetron compared with granisetron for the prevention of vomiting following strabismus surgery in children.
Topics: Analysis of Variance; Antiemetics; Benzimidazoles; Child; Child, Preschool; Double-Blind Method; Female; Granisetron; Humans; Injections, Intravenous; Male; Postoperative Nausea and Vomiting; Strabismus; Treatment Outcome | 2001 |
[Evaluation of efficacy of ramosetron orally disintegrating tablets and patient preference as to the dosage form in gynecological cancer chemotherapy].
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Endometrial Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Serotonin Antagonists; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting, Anticipatory | 2001 |
[Nasea injection in the prophylaxis of gastrointestinal reaction induced by chemotherapeutic agents].
Topics: Adolescent; Adult; Aged; Anorexia; Antiemetics; Benzimidazoles; Cisplatin; Digestive System; Female; Granisetron; Humans; Male; Middle Aged; Mitomycin; Nausea; Vomiting | 2000 |
Comparison of granisetron and ramosetron for the prevention of nausea and vomiting after thyroidectomy.
Topics: Adult; Antiemetics; Benzimidazoles; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Postoperative Nausea and Vomiting; Thyroidectomy; Treatment Outcome | 2002 |
Prophylactic antiemetic efficacy of granisetron or ramosetron in patients undergoing thyroidectomy.
Topics: Adult; Antiemetics; Benzimidazoles; Double-Blind Method; Female; Granisetron; Humans; Incidence; Male; Postoperative Nausea and Vomiting; Prospective Studies; Thyroidectomy; Time Factors | 2002 |
Clinical comparison of the selective serotonin3 antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea and anorexia.
Topics: Adolescent; Adult; Aged; Anorexia; Antiemetics; Antineoplastic Agents; Benzimidazoles; Cisplatin; Cross-Over Studies; Doxorubicin; Female; Granisetron; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Serotonin Antagonists; Single-Blind Method; Vomiting, Anticipatory | 2002 |
A double-blind, crossover, randomized comparison of granisetron and ramosetron for the prevention of acute and delayed cisplatin-induced emesis in patients with gastrointestinal cancer: is patient preference a better primary endpoint?
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Benzimidazoles; Cisplatin; Cross-Over Studies; Double-Blind Method; Endpoint Determination; Esophageal Neoplasms; Female; Granisetron; Humans; Male; Middle Aged; Patient Satisfaction; Vomiting | 2003 |
[Preventive effects of ramosetron and granisetron in prevention of gastrointestinal reaction associated with chemotherapeutic agents: a comparative study].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Appetite; Benzimidazoles; Cisplatin; Doxorubicin; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Vomiting | 2003 |
Comparative clinical study of the anti-emetic effects of oral ramosetron and injected granisetron in patients with malignant glioma undergoing ACNU chemotherapy.
Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Brain Neoplasms; Female; Glioma; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Vomiting | 2005 |
Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cisplatin; Dizziness; Double-Blind Method; Drug Administration Schedule; Endpoint Determination; Female; Granisetron; Headache; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting, Anticipatory | 2005 |
Comparison of palonosetron, granisetron, and ramosetron for the prevention of postoperative nausea and vomiting after laparoscopic gynecologic surgery: a prospective randomized trial.
Topics: Adult; Aged; Benzimidazoles; Double-Blind Method; Female; Granisetron; Gynecologic Surgical Procedures; Humans; Isoquinolines; Laparoscopy; Middle Aged; Palonosetron; Postoperative Nausea and Vomiting; Prospective Studies; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists | 2015 |
17 other study(ies) available for ramosetron and granisetron
| Article | Year |
|---|---|
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.
Topics: Animals; Cell Line; Disease Models, Animal; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Mice; Microsomes, Liver; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Agonists | 2011 |
Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue.
Topics: Animals; Benzimidazoles; Dogs; Female; Granisetron; Guinea Pigs; Imidazoles; Indazoles; Male; Muscle, Smooth; Muscle, Smooth, Vascular; Myocardial Contraction; Ondansetron; Receptors, Adrenergic; Receptors, Histamine; Serotonin Antagonists; Stereoisomerism | 1991 |
Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex.
Topics: Animals; Benzimidazoles; Cerebral Cortex; Dose-Response Relationship, Drug; Electrophysiology; Granisetron; Kinetics; Male; Ondansetron; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Vagus Nerve | 1995 |
Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.
Topics: Animals; Benzimidazoles; Bradycardia; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Granisetron; Guinea Pigs; In Vitro Techniques; Indolizines; Injections, Intravenous; Male; Muscle Contraction; Muscle, Smooth; Ondansetron; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Structure-Activity Relationship | 1994 |
Pharmacological properties of KF18259, a novel 5-HT3-receptor antagonist, in rats: inhibition of the distal colonic function.
Topics: Animals; Benzimidazoles; Cisplatin; Colon; Defecation; Gastric Emptying; Gastrointestinal Motility; Granisetron; Male; Ondansetron; Quinolines; Rats; Rats, Sprague-Dawley; Reflex; Serotonin; Serotonin Antagonists | 1993 |
Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents.
Topics: Animals; Benzimidazoles; Cisplatin; Dose-Response Relationship, Drug; Gastric Emptying; Granisetron; Guinea Pigs; Male; Ondansetron; Rats; Rats, Wistar; Serotonin Antagonists | 1995 |
Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats.
Topics: Animals; Benzamides; Benzimidazoles; Blood Glucose; Cisapride; Diabetes Mellitus, Experimental; Gastric Emptying; Gastrointestinal Motility; Gastroparesis; Granisetron; Male; Morpholines; Ondansetron; Piperidines; Pyrroles; Rats; Rats, Wistar; Serotonin Antagonists; Serotonin Receptor Agonists; Vagotomy | 1997 |
Comparative study of [3H]ramosetron and [3H]granisetron binding in the cloned human 5-hydroxytryptamine3 receptors.
Topics: Animals; Benzimidazoles; Binding, Competitive; Cell Membrane; COS Cells; Granisetron; Humans; Kinetics; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Recombinant Fusion Proteins; Tritium | 1998 |
Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
Topics: Animals; Benzimidazoles; Dose-Response Relationship, Drug; Drug Interactions; Ferrets; Granisetron; Ileum; Male; Ondansetron; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1999 |
Effects of ondansetron, granisetron, ramosetron, and azasetron on human neutrophil functions.
Topics: Antiemetics; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Chemotaxis, Leukocyte; Granisetron; Humans; Neutrophils; Ondansetron; Oxazines | 2002 |
[Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granisetron; Humans; Ifosfamide; Male; Middle Aged; Nausea; Ondansetron; Osteosarcoma; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2007 |
[Clinical evaluation of antiemetic effects of 5-hydroxytryptamine receptor type 3 (5HT3 receptor) antagonists based on changes in eating condition in cancer patients receiving chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Eating; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Oxazines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Vomiting | 2008 |
Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Drug Administration Schedule; Granisetron; Humans; Indoles; Models, Theoretical; Ondansetron; Oxazines; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Tropisetron; Vomiting | 2009 |
Retraction record rocks community.
Topics: Anesthesiology; Benzimidazoles; Clinical Trials as Topic; Granisetron; Humans; Japan; Research Personnel; Retraction of Publication as Topic; Scientific Misconduct; Societies, Medical; Whistleblowing | 2012 |
Efficacy and safety of an increased-dose of dexamethasone in patients receiving fosaprepitant chemotherapy in Japan.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Benzimidazoles; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Japan; Male; Middle Aged; Morpholines; Neoplasms; Palonosetron; Quinuclidines; Retrospective Studies; Serotonin Antagonists; Vomiting | 2014 |
Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study.
Topics: Adult; Antiemetics; Antineoplastic Agents; Benzimidazoles; Bleomycin; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Palonosetron; Platinum Compounds; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Testicular Neoplasms; Vomiting | 2021 |
Effects of 5-HT
Topics: Acute Kidney Injury; Aged; Animals; Benzimidazoles; Cisplatin; Disease Models, Animal; Female; Granisetron; Humans; Kidney; Male; Mice; Middle Aged; Nausea; Ondansetron; Organic Cation Transport Proteins; Palonosetron; Renal Elimination; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2021 |